Board certified rheumatologist Dr. Mahsa Tehrani discusses Novo Nordisk's decision to dramatically cut the U.S. list prices for its popular diabetes and
NEWYou can now listen to Fox News articles!
The U.S. Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection.
The 7.2 mg dosage, called … [+4710 chars]
